PHARMACEUTICAL IP

Launch of Evolve Webinars!

  • Sector: Uncategorized
A series of live webinars on IP strategy for pharma & biotech professionals.
 

We are thrilled to announce the launch of Evolve Webinars!

Are you a biotech/pharma industry professional with an interest in business orientated, practical IP strategy?

If “yes”, then Evolve is launching a live webinar series perfect for you!

In our Evolve webinar series we will share strategies for navigating the complex world of biotech and pharma IP. We can promise engaging and thought-provoking discussions.

Our first live webinar, “Unlocking the potential of cell & gene therapies with effective IP strategy“, will be held on 11 July 2025, 1pm BST. Places are limited, so register now to avoid disappointment.

Subscribe to our mailing list to be the first to hear about our upcoming webinars.

Related insights...

Evolve’s Steven Gurney recognised in IAM 1000 2025

We are delighted to announce that Evolve’s founder Steven Gurney has once again be recognised in the IAM patent 1000.

Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy

Navigating European pharma and biotech patent litigation is more complex than ever, with ongoing debates on plausibility, UPC intricacies, claim interpretation, and divergent strategies for antibody inventions.

Rose Hughes joins Evolve

Evolve Intellectual Property is pleased to welcome Dr. Rose Hughes as our new Patent Attorney.

Evolve joins the ranks of the Legal 500

We are delighted to announce that Evolve has joined the ranks of the Legal 500 Intellectual Property firms. The Legal 500 is one of the UK’s leading legal directories, known for its rigorous research methodology and independent analysis of the legal market. As a small boutique IP firm, we are particularly proud of this achievement. …
All Insights